The results showed that RFC2 was generally highly expressed in many types of cancer tissues compared with normal tissues, including brain and CNS cancer, colorectal cancer, gastric cancer, head and neck cancer, kidney cancer, myeloma, ovarian cancer, sarcoma, and other cancer (Fig. 1A). This evidence concerns the gene RFC2 and ovarian cancer.